Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

Overview

The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: * treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) * Rate of early and late symptomatic VTE recurrence * Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension * Rate of bleeding complications * Rate of all-cause mortality at six months

Other objectives are to clarify the additional outcomes of: * Stroke (Measured by number of incidences) * Transient Ischemic Attack (TIA) (Measured by number on incidences) * ST Elevated Myocardial Infarction (STEMI) (Measured by number of incidences) * Non-ST Elevated Myocardial Infraction (NSTEMI) (Measured by number of incidences) * Unstable Angina (Measured by number of incidences) * Quality of life and patient reported outcomes and costs associated with the management of VTE.

Conditions

Eligibility